Europe's energy giant BP plc (NYSE: BP) is considering a range of options for its Brazilian biofuels business, including a sale, as CEO Meg O'Neill accelerates a reshaping of the company's portfolio and concentrates capital on core operations, underscoring how persistently elevated international oil prices are pushing management to prioritize core oil and gas activities and debt reduction.

The business only became wholly owned in 2024 after BP acquired the remaining 50% stake, and it may now return to the divestment list, reflecting the CEO's reordering of capital allocation priorities.

The potential transaction, alongside adjustments to Castrol, refining and renewable energy assets, points to a single objective: boosting cash recovery capacity, repairing the balance sheet and improving shareholder returns.

However, the Brazilian business sale remains in early-stage discussions and no final decision has been made.

As of Asian morning trading on September 29 Beijing time, the front-month Brent crude futures contract, the international oil benchmark, was quoted at $105.91 per barrel, up about 46.1% from $72.48 on February 27, the last trading day before the U.S. and Israel launched military action against Iran.

On a settlement basis, Brent closed at $105.28 on September 28, up about 45.3% from pre-war levels and up about 17.9% from $89.31 on August 28.

The most direct catalyst for the latest leg of the oil rally was Trump's rejection of Iran's proposal to reopen the strait, which once again dented expectations for a supply recovery; Qatar subsequently pushed for separate consultations with Iranian Foreign Minister Araghchi and the U.S. side to discuss a revised version of the earlier seven-day proposal, causing oil prices to partially give back gains.

What the market is really trading is whether energy transportation can return to normal: even if export volumes recover somewhat, restricted strait passage and alternative methods such as ship-to-ship transfers still raise transportation costs and delivery uncertainty, leaving international oil prices pulled by both supply constraints and diplomatic developments.

From Full Acquisition to Possible Sale: Brazilian Business Reflects BP's Strategic Shift

According to people familiar with the matter, BP is considering a range of options for its Brazilian biofuels business, including a sale, as CEO Meg O'Neill accelerates a reshaping of the energy giant's portfolio and concentrates capital on core operations.

BP previously acquired 50% of the business in 2024 for $1.4 billion including debt, gaining control.

The people said the company no longer views the business as core to its future strategy, adding that discussions about a sale are still at an early stage and no final decision has been made on whether to proceed.

A BP representative declined to comment.

If a deal is reached, it would mark another step in BP's broader effort to simplify its portfolio, raise funds for core oil and gas operations and repay debt.

The company has committed to divesting about $20 billion in assets by 2027 to cut debt, reduce costs and improve returns.

Former CEO Murray Auchincloss announced a strategic shift last year, reversing the more aggressive energy transition investment path pursued under his predecessor Bernard Looney.

The potential sale would also mark a notable reversal for BP's Brazilian bioenergy business.

In 2024, BP management agreed to pay $1.4 billion to acquire the remaining 50% stake held by Bunge Global in their Brazilian sugar and ethanol joint venture, achieving full ownership.

At the time, BP described the platform as a bioenergy business with scale expansion potential and cost competitiveness, and said it planned to pursue further opportunities in ethanol, sustainable aviation fuel and biogas.

That strategy subsequently came under pressure as BP reassessed investments outside traditional oil and gas.

The company has scaled back new low-carbon projects and other related investment plans while advancing the sale of various assets.

BP agreed last December to sell a 65% stake in its lubricants business Castrol to Stonepeak, retaining 35%; this summer, it completed the sale of its Gelsenkirchen refinery in Germany to Klesch Group.

As part of its overall divestment plan, the company has also been seeking to sell its Lightsource solar and battery business.

In 2024, BP likewise acquired the remaining stake in Lightsource, but soon after turned to seeking to divest the business.

This year, Brazil's Petrobras purchased a 49.99% stake in Lightsource's Brazilian subsidiary.

Selling the Brazilian biofuels business would provide BP with another potentially sizable source of funds while allowing the company to redirect capital toward debt repayment, oil and gas operations and other businesses seen as offering higher returns.

From Oil Price Bonanza to Shareholder Returns: BP's High-Profile "Cash Flow Recovery Battle"

The core logic behind Morgan Stanley's recent bullish view on BP is the combined improvement in cash flow, debt reduction and upstream growth prospects.

The bank maintained an "overweight" rating in early September and raised its target price for the London-listed ordinary shares from 519 pence to 598 pence.

According to a research note published on September 8, Morgan Stanley expects BP to generate about $17 billion in free cash flow in 2027, corresponding to a free cash flow yield of about 15%, above the peer average of about 11%; this measures free cash flow relative to market capitalization, not the dividend yield.

The bank also favors the decline in net debt, the potential restart of buybacks and the catalytic effect of appraisal work at Brazil's Bumerangue oilfield.

Another Wall Street giant, JPMorgan, said that from a cash flow perspective, with production and costs under control, high oil prices can expand oil and gas producers' operating cash surplus, supporting debt repayment, dividends and buybacks.

This is why Wall Street financial giants such as JPMorgan, Goldman Sachs and Morgan Stanley have recently issued frequent bullish research notes on energy majors.

The key logic behind JPMorgan's recent bullish view on BP is that this cash flow, combined with internal restructuring, is expected to drive financial repair and shareholder return growth.

Under a base-case assumption of Brent crude at $75 per barrel in 2027, JPMorgan still expects BP's total financial obligations to fall by 50% by the end of 2027, and believes the value created by restructuring is equivalent to high-single-digit annual growth in underlying earnings per share over three years, raising its target price by about 22.7% to 675 pence.

This logic points to a lower debt burden, improved financial expenses and more value released to shareholders.

Wall Street's overall bullish investment logic on BP can be summed up to some extent as a "cash flow recovery battle": high oil prices enhance the revenue-generating capacity of upstream assets with normal production and delivery capabilities, while monetizing non-core assets is expected to accelerate debt reduction, lower subsequent interest burdens and free up space for core business investment and shareholder distributions.

BP recently stated clearly that it aims to announce about $20 billion in divestment transactions by the end of 2027; this target does not mean all transaction proceeds will have been received by then.

What truly determines whether the revaluation can be delivered is the sale price, the actual scale of debt reduction, and the continued revenue-generating capacity of the remaining assets after excluding the divested businesses.